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Hypertension and Cerebral Diffusion Tensor Imaging in
Small Vessel Disease
Rob A.R. Gons, MD; Karlijn F. de Laat, MD; Anouk G.W. van Norden, MD;
Lucas J.B. van Oudheusden, MD; Inge W.M. van Uden, MD; David G. Norris, PhD;
Marcel P. Zwiers, PhD; Frank-Erik de Leeuw, MD, PhD
Background and Purpose—Hypertension is a risk factor for cerebral small vessel disease, which includes white matter
lesions (WML) and lacunar infarcts. These lesions are frequently observed on MRI scans of elderly people and play a
role in cognitive decline. Preferably, one would like to evaluate the effect of hypertension before fluid-attenuated
inversion recovery visible macrostructural lesions occur, possibly by investigating its effect on the microstructural
integrity of the white matter. Diffusion tensor imaging provides measures of structural integrity.
Methods—In 503 patients with small vessel disease, aged between 50 and 85 years, we cross-sectionally studied the
relation between blood pressure, hypertension, and hypertension treatment status and diffusion tensor imaging
parameters in both normal-appearing white matter (NAWM) and WMLs. All of the subjects underwent 1.5-T MRI and
diffusion tensor imaging scanning. Fractional anisotropy and mean diffusivity were calculated in both NAWM and WMLs.
Results—Increased blood pressure and hypertension were significantly related to lower fractional anisotropy in both
NAWM and WMLs and to higher mean diffusivity in WMLs. For hypertensives, odds ratios for the risk of impaired
microstructural integrity (fractional anisotropy) were 3.1 (95% CI: 1.8 to 5.7) and 2.1 (95% CI: 1.2 to 3.5) in NAWM
and WMLs, respectively, compared with normotensives. Fractional anisotropy odds ratios for treated uncontrolled
subjects were 6.5 (95% CI: 3.3 to 12.7) and 2.7 (95% CI: 1.5 to 5.1) in NAWM and WMLs, respectively, compared with
normotensives.
Conclusions—Our data show that diffusion tensor imaging may be an appropriate tool to monitor the effect of blood
pressure and the response to treatment on white matter integrity, probably even before the development of WMLs on
fluid-attenuated inversion recovery. (Stroke. 2010;41:2801-2806.)
Key Words: hypertension  blood pressure  diffusion tensor imaging  cerebral small vessel disease
 white matter
Cerebral small vessel disease (SVD) is radiologicallycharacterized by the presence of lacunar infarcts and
white matter lesions (WMLs).1 These are common findings
on cerebral MRI scans of both participants from population-
based studies and cognitively impaired elderly patients.2 WMLs
are presumably caused by vascular risk factors, especially
hypertension.3 They are related to gait disturbances,4 cognitive
decline, and, ultimately, to dementia in some.5 However, not all
individuals with an apparent identical degree of WMLs on
conventional imaging experience the same level of cognitive
impairment or have the same risk for dementia.6 One explana-
tion might be that identical-appearing WMLs on conventional
fluid-attenuated inversion recovery (FLAIR) differ in underlying
pathology. Another is that the normal-appearing white matter
(NAWM) on conventional imaging has undergone structural
changes, for example, under the influence of the same vascular
risk factors known to be related to WMLs that are beyond the
detection limit of FLAIR imaging. There is some pathological
proof for both of these explanations.7,8 However, in vivo
assessment of the microstructural integrity of the cerebral white
matter has only become available recently with the introduction
of diffusion tensor imaging (DTI).
DTI provides quantitative information about the structural
integrity of the white matter.9,10 This technique is based on
the principle of molecular diffusion of water and provides,
among others, 2 parameters, fractional anisotropy (FA) and
mean diffusivity (MD). FA reflects the directionality of
diffusion, whereas MD reflects the degree of diffusivity. FA
decreases and MD increases are typical indications of im-
paired structural integrity.11
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Although hypertension is the preeminent risk factor for
SVD, little is known of its effect on the microstructural
integrity of the white matter. A small study including 30
elderly (range of age: 60 to 70 years) hypertensive subjects
without WMLs on conventional MRI showed no significant
differences with respect to the FA in several brain structures,
apart from the optic radiation, compared with healthy (range
of age: 60 to 76 years) controls.12 Nitkunan et al13 found an
increase in MD and corresponding decrease in FA in both
NAWM and white matter hyperintensities in the centrum
semiovale, from normotension, through hypertension to
symptomatic cerebral SVD in 134 subjects. Recently, Mac-
lullich et al14 found a positive and significant correlation
between systolic blood pressure and MD in 6 regions of
interest in NAWM.
Hypertension is an established risk factor for the develop-
ment of WML. Adequate blood pressure–lowering treatment
has been found to be related to a reduced risk of WMLs and
their progression in longitudinal studies.15,16 To date, it is
unknown whether similar effects of hypertension treatment
on the microstructural integrity of both NAWM and WMLs
exist.
We, therefore, hypothesized that blood pressure and hy-
pertension would be negatively related to the microstructural
integrity of both NAWM and WMLs and that proper treat-
ment would be positively related to a higher degree of
microstructural integrity than those with uncontrolled hyper-
tension, despite blood pressure–lowering treatment. We,
therefore, investigated the effect of blood pressure and its
treatment status on the microstructural integrity in both
NAWM and WMLs among 503 otherwise healthy, indepen-
dently living elderly subjects with SVD.
Patients and Methods
The Radboud University Nijmegen Diffusion Tensor and MRI
Cohort Study was designed to investigate risk factors and cognitive,
motor, and mood consequences of brain changes during aging as
assessed by (among other techniques) DTI and conventional struc-
tural MRI among nondemented elderly with cerebral SVD.
In 2006, consecutive patients from the department of neurology of
our hospital who had undergone neuroimaging between October
2002 and November 2006 were selected for possible participation in
the study. Inclusion criteria were as follows: (1) age between 50 and
85 years; (2) cerebral SVD on neuroimaging; and (3) acute (n219)
or subacute (n284) clinical symptoms of SVD. Patients who were
eligible because of a lacunar syndrome were included only 6
months after the event to avoid acute effects on the outcomes.
Exclusion criteria were as follows: (1) dementia according to the
international diagnostic criteria17–19; (2) Parkinson(ism) according to
the international diagnostic criteria; (3) life expectancy of 6
months; (4) intracranial space occupying lesion; (5) (psychiatric)
disease interfering with cognitive testing or follow-up; (6) recent or
current use of acetylcholine-esterase inhibitors, neuroleptic agents,
L-dopa or dopa-a(nta)gonists; (7) WML mimics (eg, multiple scle-
rosis and irradiation induced gliosis); (8) prominent visual or hearing
impairment; (9) language barrier; and (10) MRI contraindications or
known claustrophobia.
From 1004 invited individuals, 727 were eligible and 525 agreed
to participate. Complete information, including a cerebral MRI scan,
was obtained from 503 individuals, because in 22 individuals
exclusion criteria were found during their visit to our research center
(14 with unexpected claustrophobia, 1 died before MRI scanning, 1
was diagnosed with multiple sclerosis, in 1 there was a language
barrier, 1 subject fulfilled the criteria for Parkinson disease, and 4
met the dementia criteria). The response was 71.3% (503 of 705).
These 503 individuals had symptoms of transient ischemic attack or
lacunar syndrome (n219), cognitive disturbances (n245), motor
disturbances (n97), depressive symptoms (n100), or a combina-
tion thereof. The Medical Review Ethics Committee region Arnhem-
Nijmegen approved the study. All of the participants signed an
informed consent form.
Measurement of Blood Pressure
Blood pressure was measured 3 times in the supine position after 5
minutes of rest by an experienced research nurse. The average of
these 3 measurements of systolic and diastolic blood pressures was
used. Hypertension was defined as systolic blood pressure
140 mm Hg or diastolic blood pressure90 mm Hg and/or the use
of blood pressure–lowering agents.20 Information on blood pressure–
lowering medication was collected by means of a structured, com-
puterized questionnaire, which was filled in by a resident in
neurology.
Other Covariates
Height and weight were measured in light clothing without shoes,
and body mass index was calculated as weight divided by height (in
meters) squared. Information on smoking behavior (current, former,
and never) was obtained through a standardized, structured question-
naire, which was checked during the interview. Diabetes mellitus and
hypercholesterolemia were considered to be present if the participant
was taking oral glucose–lowering drugs or insulin or lipid-lowering
drugs, respectively.
Conventional MRI Scanning Protocol
MRI scanning was performed on a 1.5-T scanner (Siemens Magne-
ton Sonata). The protocol included the following whole brain scans:
T1 3D magnetization-prepared rapid acquisition with gradient echo
imaging (repetition time [TR]/echo time [TE]/inversion time [TI]:
2250/3.68/850 ms; flip angle: 15°; voxel size: 1.01.01.0 mm);
DTI (TR/TE: 10 100/93 ms; voxel size: 2.52.52.5 mm; 4
unweighted scans, 30 diffusion-weighted scans with b value 900
s/mm2); FLAIR pulse sequences (TR/TE/TI: 9000/84/2200 ms;
voxel size: 1.01.26.0 mm [including an interslice gap of 1 mm];
number of excitations2). The complete scanning protocol took 31
minutes. All of the MRI scans were made on the same scanner.
Conventional MRI Analysis
All of the images were evaluated without previous notice of any
clinical parameter. WMLs were considered present in case these
were hyperintense on FLAIR MRI and not or only faintly hypoin-
tense on T1-weighted image. Gliosis surrounding lacunar and terri-
torial infarctions was not considered as WMLs.21–23 WMLs were
manually segmented on the FLAIR image on a Intuos3 graphics
tablet (Wacom Co), by 2 experienced raters, with a high interrater
agreement (intraclass correlation coefficient for total volume: 0.99).
Total WML volume was calculated as the sum of all of the
segmented areas multiplied by slice thickness.
Normalization parameters to the ICBM152 linear template (as
provided with SPM5, Wellcome Department of Cognitive Neurol-
ogy, University College London, London, United Kingdom) and
gray and white matter tissue probability maps were computed by
using SPM5 unified segmentation routines on the T1 magnetization-
prepared rapid acquisition with gradient echo images.24 Total gray
and white matter volumes were calculated by summing all of the
voxel volumes that had a P0.5 for belonging to the tissue class.
Coregistration parameters of the FLAIR image to the T1 image were
computed (SPM5 mutual information coregistration) and used to
bring both the FLAIR and WML segmentation images into the
subject’s (anatomic) reference frame. Transformed images were
visually checked for coregistration errors. Subsequently, the WML
segmentations were resampled to and combined with the white
matter maps to yield to a WML map (the intersection of WML and
white matter) and NAWM map (the complement of WMLs in white
matter) in the T1 reference space.
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DTI Analysis
The diffusion-weighted images of each subject were realigned on the
unweighted image using mutual information routines from SPM5.
Then, the diffusion tensor25 and its eigenvalues were computed using
an SPM5 add-on (http://sourceforge.net/projects/spmtools). Un-
physical spurious negative eigenvalues of the diffusion tensor were
set to 0, after which the tensor derivatives of the FA and MD were
calculated.26 The mean unweighted image was used to compute the
coregistration parameters to the anatomic reference image (SPM5
mutual information coregistration), which were then applied to all of
the diffusion-weighted images and results. All of the images were
visually checked for motion artifacts and coregistration errors, which
resulted in a final sample of 499 subjects because of the exclusion of
4 excessive motion artifacts.
Regions of Interest
FA and MD measurements were obtained for selected areas in which
virtually all of the voxels were in the NAWM, using region of
interest (ROI) analyses. Four ROIs were hand drawn unilaterally on
axial slices of the Montreal Neurological Institute T1 template by an
experienced neurologist (F.-E.d.L.). ROIs were a sphere with a
diameter of 10 mm. Two slices, including the anterior horns of the
lateral ventricles (frontal), and 2 slices, including the posterior horns
(occipital), were chosen for assessment of periventricular and sub-
cortical frontal and parieto-occipital NAWM. For each slice, 2 ROIs
were placed in the right hemisphere and subsequently mirrored to the
left hemisphere. To minimize partial volume effects, ROIs were
positioned at a sufficient distance from the edge of the ventricles and
the cortical gray matter. ROIs were then translated onto the corre-
sponding FA and MD maps. FA and MD values within each ROI
were averaged.
Statistical Analysis
The relation between blood pressure and WML volume was assessed
by multiple regression analysis, adjusted for age, sex, and cardio-
vascular risk factors, including diabetes mellitus, hypercholesterol-
emia, smoking behavior, and body mass index. The same was done
for the relation between blood pressure and DTI parameters (FA and
MD) in both NAWM and WMLs.
The mean difference in FA and MD between hypertensives and
those without was assessed by means of ANCOVA, adjusted for age,
sex, and cardiovascular risk factors. The same difference was
calculated for hypertension treatment status in NAWM and WMLs,
as well as in ROIs. Subjects who were normotensive with medication
were considered treated controlled, whereas subjects who were still
hypertensive despite medication were considered treated uncon-
trolled. Finally, hypertensive subjects without medication were
defined as untreated. Mean WML volume values were calculated for
the different patient groups, adjusted for age, sex, and cardiovascular
risk factors by means of ANOVA. The association among hyperten-
sion, hypertension treatment status, and the risk of impaired micro-
structural integrity (defined as the lower tertile of the FA distribution
and the upper tertile of the MD distribution) of the white matter as
the outcome variable was assessed by logistic regression, adjusted
for age, sex, and cardiovascular risk factors, with normotensive
subjects as the reference group. Statistical analyses were performed
using the software package SPSS (version 17.0, SPSS Inc).
Results
Table 1 presents the baseline characteristics of the study
population. Of the 499 subjects, 43.5% were women. The
mean age was 65.6 years (SD: 8.8 years). The mean systolic
blood pressure was 140.7 mm Hg (SD: 20.7 mm Hg), and the
mean diastolic blood pressure was 78.1 mm Hg (SD:
9.5 mm Hg). Of all participants, 73.5% had hypertension, of
whom 54.3% were taking antihypertensive drugs.
Systolic and diastolic blood pressure levels (per 10-mm Hg
increase) were significantly related to WML volume (1.68
[95% CI: 0.93 to 2.42; P0.001] and 2.6 [95% CI: 1.09
to 4.18; P0.001]). The Figure presents the relation between
hypertension treatment status and WML volume.
Table 2 shows the relation between blood pressure and DTI
parameters in both NAWM and WMLs. An increase in
systolic blood pressure (per 10 mm Hg) was significantly
related to a decrease of FA in both NAWM (0.19 [95%
CI:0.27 to0.11]; P0.001) and WMLs (0.25 [95%
CI: 0.39 to 0.12]; P0.001). The same was true for each
10-mm Hg increase in diastolic blood pressure (0.32
Table 1. Characteristics of the Total Study Population
Variable Data
No. of subjects 499
No. according to age (%)
50 to 60 y 161 (32.3)
60 to 70 y 161 (32.3)
70 to 85 y 177 (35.4)
Age, y 65.6 (8.8)
Women, n (%) 217 (43.5)
Systolic blood pressure, mm Hg 140.7 (20.7)
Diastolic blood pressure, mm Hg 78.1 (9.5)
Hypertension* 367 (73.5)
Use of antihypertensive drugs, n (%) 271 (54.3)
Diabetes mellitus, n (%) 73 (14.6)
Use of lipid lowering drugs, n (%) 234 (46.9)
Body mass index, kg/m2 27.1 (4.1)
Smokers, n (%)
Current 75 (15.0)
Former 275 (55.1)
Never 149 (29.9)
WML volume, mL 7.14 (3.45 to 18.1)
Territorial infarctions, n (%) 59 (11.7)
Data represent mean (SD), median (interquartile range), or n (%).
*Hypertension is indicated by blood pressure140/90 mm Hg and/or use of
antihypertensive drugs.
Figure. Relation between WML volume† and hypertension treat-
ment status.
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[95% CI:0.49 to0.16; P0.001] and 0.65 [95% CI:
0.92 to 0.38; P0.001]). A 10-mm Hg increase in both
systolic and diastolic blood pressures was significantly re-
lated to an increase in MD in WML (0.04 [95% CI: 0.01
to 0.06; P0.005] and 0.06 [95% CI: 0.01 to 0.11;
P0.027]). In NAWM, this was only found for systolic blood
pressure (0.02 [95% CI: 0.00 to 0.03]; P0.022). Nor-
malization of WML by intracranial volume did not alter the
magnitude of these relations, nor did these relations change
when controlling for WML volume as a possible confounder,
in particular, in NAWM analyses. Actual values of FA and
MD for NAWM and WMLs are presented in Table 3.
Subjects with hypertension had a significantly lower mean
FA in NAWM and WMLs than those without (mean differ-
ence: 0.80102, P0.001; 0.91102, P0.004). Hyper-
tensives also had a higher MD in both NAWM and WMLs
(mean difference: 0.11 mm2/s107, P0.002; 0.02 mm2/s
107, P0.001) than normotensives. Treated uncontrolled
subjects had a significantly lower mean FA value in both
NAWM and WMLs (mean difference: 0.73102, P0.001;
0.78102, P0.03) and a higher mean MD value in
NAWM (mean difference: 0.09 mm2/s107; P0.03) com-
pared with treated controlled subjects. Although treated
controlled participants did not differ with respect to their
mean FA in WML (mean difference: 0.71102, P0.06)
from normotensives, they had a significantly lower mean FA in
NAWM (mean difference: 0.70102; P0.003; Table 4).
Similar results were found in ROI-based analyses (Table 5).
Individuals with hypertension had an increased risk, as
estimated by odds ratios, of impaired microstructural integrity
of both NAWM and WMLs (odds ratio: 3.1 [95% CI: 1.8 to
5.7]) and 2.1 [1.2 to 3.5]) compared with normotensives. For
treated uncontrolled subjects, the odds ratios for impaired
microstructural integrity were 6.5 (95% CI: 3.3 to 12.7) and
2.7 (95% CI: 1.5 to 5.1) in NAWM and WMLs compared
with normotensives. Similar relations were found for MD
(Table 6). Stratified analyses for both acute and subacute
manifestations of SVD did not alter the magnitude of the
associations (data not shown).
Table 2. Relation Between Blood Pressure (per 10-mm Hg
Increase) and DTI Parameters in Both NAWM and WML
DTI Parameters†
Blood Pressure
Systolic Diastolic
 95% CI  95% CI
FA
NAWM 0.19** 0.27 to0.11 0.32** 0.49 to0.16
WML 0.25** 0.39 to0.12 0.65** 0.92 to0.38
MD
NAWM 0.02* 0.00 to 0.03 0.01 0.02 to 0.05
WML 0.04* 0.01 to 0.06 0.06* 0.01 to 0.11
Values represent  (per 10-mm Hg blood pressure increase) and 95% CI.
Data were adjusted for age, sex, and cardiovascular risk factors.
*P0.05.
**P0.001.
†Data show FA, fractional anisotropy (102); MD, mean diffusivity
(mm2/s107).
Table 3. FA and MD Values for NAWM and WMLs by
Hypertension Treatment Status
DTI
Parameters*
Hypertension Treatment Status
Normotensives
(n132)
Treated
Controlled
(n120)
Treated
Uncontrolled
(n151)
Untreated
(n96)
FA
NAWM 33.6 32.9 31.8 32.9
WML 34.9 33.9 32.6 33.8
MD
NAWM 8.7 8.9 9.1 8.8
WML 9.7 10.0 10.3 9.9
*FA indicates fractional anisotropy (102); MD, mean diffusivity
(mm2/s107).
Table 4. DTI Parameters in NAWM and WML by Treatment Status
DTI
Parameters§
Hypertension,
All†
Hypertension Treatment Status
Treated
Controlled
(n120)
Treated
Uncontrolled
(n151)
Untreated
(n96)
FA
NAWM 0.80** 0.70* 1.43** 0.41
WML 0.91* 0.71 1.50** 0.66
MD
NAWM 0.11* 0.12* 0.21** 0.02
WML 0.02* 0.21* 0.33** 0.07
Values are estimated mean differences calculated by ANCOVA, adjusted for
age, sex, and cardiovascular risk factors. Normotensives are the reference
group.
*P0.05.
**P0.001.
†Hypertension is shown by systolic blood pressure 140 mm Hg or systolic
blood pressure 90 mm Hg and/or use of antihypertensive drugs.
§FA indicates fractional anisotropy (102); MD, mean diffusivity
(mm2/s107).
Table 5. Fractional Anisotropy in NAWM From ROIs, by
Hypertension Treatment Status
Fractional
Anisotropy, ROI§
Hypertension,
All†
Hypertension Treatment Status
Treated
Controlled
(n120)
Treated
Uncontrolled
(n151)
Untreated
(n96)
Frontal 0.99 0.88 2.00* 0.32
Frontal periventricular 1.98* 1.54* 3.66** 1.09
Parieto-occipital 2.84** 3.33** 4.08** 1.37
Parieto-occipital
periventricular
0.92 0.58 2.47* 0.05
Values are estimated mean differences calculated by ANCOVA, adjusted for
age, sex, and cardiovascular risk factors. Normotensives are the reference
group.
*P0.05.
**P0.001.
†Hypertension is shown by systolic blood pressure 140 mm Hg or systolic
blood pressure 90 mm Hg and/or use of antihypertensive drugs.
§FA indicates fractional anisotropy (102).
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Discussion
We found a linear relation between blood pressure levels and
the microstructural integrity of both NAWM and WMLs. In
hypertensives, the microstructural integrity of the cerebral
white matter was significantly more affected than in normo-
tensives. This is supported by a recent study which showed
that high blood pressure was associated with lower FA values
in the dorsal anterior cingulate and in multiple frontostriatal
and frontotemporal white matter regions in 41 patients (mean
age: 70.1 years) with major depression.27 Our data further
suggest that effective treatment of hypertension may reduce
the risk of impaired microstructural integrity, although we did
not perform an intervention study. These data are consistent
with the results from previous longitudinal population-based
studies that investigated the role of hypertension and its
treatment status on the presence of WML on conventional
FLAIR MRI.15,16,28 More interestingly, we found loss of
microstructural integrity in the NAWM as well, which could
explain the fact that cognitive performances can differ be-
tween individuals with an apparent identical degree of white
matter hyperintensities on conventional imaging. This is
supported by recent work, in which microstructural integrity
of both WMLs and NAWM was associated with cognitive
function, regardless of white matter atrophy and WML
volume.29 Microstructural changes in the white matter, not
visible on FLAIR, may, therefore, add to cognitive decline.
The underlying neuropathology of impaired microstruc-
tural integrity as assessed with DTI is not fully elucidated, but
it has been suggested that it is composed of a combination of
axonal loss and gliosis, as seen in postmortem studies on
SVD.30 Recently, a quantitative postmortem MRI study on
the heterogeneity of white matter hyperintensities in Alzhei-
mer disease showed that, in Alzheimer disease, the degree of
axonal density was an independent determinant of FA.31
More proof for the assumption of impaired microstructural
integrity comes from an MRS study that found a relation
between N-acetylaspartate, a marker for axonal loss/dysfunc-
tion, and increase in MD and reduction of FA in symptomatic
SVD subjects with white matter hyperintensities.13 Because
hypertension is a strong risk factor for SVD, it is plausible
that the hypertension-associated DTI changes found in this
study may reflect similar underlying pathology.
To our knowledge, this is the largest study to date that
investigated the effect of hypertension on the microstructural
integrity of cerebral white matter. Moreover, the association
between treatment of hypertension and microstructural integ-
rity of cerebral white matter has never been studied before.
Strong elements of our study include the fact that our study
is single center with a high response (71.3%) and the use of
standardized, structured assessment of both the risk factor and
treatment status, as well as the other covariates. All of the
WMLs were manually segmented by 2 experienced research-
ers, blinded to clinical data, with high interrater agreement.
However, some methodological issues need to be considered.
Although blood pressure measurement was based on 3
measurements after 5 minutes of rest, one cannot exclude
misclassification. Nonetheless, all of the measurements were
done without information on the degree of WML or the
structural integrity of the white matter, so we consider it
unlikely that this misclassification is related to DTI parame-
ters. Therefore, any possible measurement error is likely to be
random and would have biased our findings to the null,
leading to an underestimation of the strength of our associa-
tions. In our analyses, the relatively less structurally impaired
integrity in the untreated group compared with treated con-
trolled and treated uncontrolled subjects seems initially con-
tradictory. One likely explanation for this finding could be
that misclassification has occurred in this group. Because
classification of “untreated hypertension” was based on 3
single measurements on 1 single day, it could be, at least in
some, that their blood pressure was elevated because of a
white coat effect. This effect may have led to an overestima-
tion of the proportion of true hypertensive subjects in this
group. Consequently, these individuals do not exhibit the
accompanying impairment in the white matter’s structural
integrity, simply because they are not truly hypertensive.
Another explanation could be that the duration of hyperten-
sion among those participants with hypertension in this
untreated group is short and, therefore, without organ failure
or symptoms that prompted them to visit a doctor.
Table 6. Relation Among Hypertension, Treatment Status, and Severe Microstructural
Integrity Changes (OR and 95% CI)
DTI Parameters† Hypertension, All
Hypertension Treatment Status
Treated Controlled
(n120)
Treated Uncontrolled
(n151)
Untreated
(n96)
FA
NAWM 3.1 (1.8 to 5.7)** 2.8 (1.4 to 5.5)* 6.5 (3.3 to 12.7)** 1.7 (0.8 to 3.5)
WML 2.1 (1.2 to 3.5)* 2.1 (1.1 to 4.0)* 2.7 (1.5 to 5.1)* 1.6 (0.8 to 3.0)
MD
NAWM 1.9 (1.0 to 3.6) 1.9 (0.9 to 4.2) 4.2 (2.0 to 9.1)** 0.7 (0.3 to 1.7)
WML 2.2 (1.2 to 4.0)* 2.1 (1.0 to 4.3)* 4.0 (2.0 to 8.1)** 1.2 (0.6 to 2.5)
Data are OR (95% CI) adjusted for age, sex, and cardiovascular risk factors. Normotensives are the reference group.
FA indicates fractional anisotropy (102); MD, mean diffusivity (mm2/s107).
*P0.05.
**P0.001.
†Values represent the lower tertile of the FA and the upper tertile of the MD severity distribution.
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In conclusion, DTI may add to our understanding of the
very early loss of microstructural integrity of the white matter
given our finding of a relation between the level of blood
pressure and of the DTI parameters in the NAWM, beyond
the limits of visibility on conventional FLAIR imaging.
Follow-up studies are needed to study whether areas of
reduced microstructural integrity ultimately develop into
FLAIR-visible WML. Adequate hypertension treatment was
related to a higher degree of microstructural integrity of the
cerebral white matter and thereby offers the possibility of
postponing or preventing the emergence of FLAIR-visible
WML, although this needs to be investigated in prospective
intervention studies.
Future studies should not only investigate more in-depth
pathophysiological mechanisms of the transition from
NAWM to WMLs but also take its cognitive or motor
consequences into account. When proven, DTI parameters
could play a role as biomarkers for disease progression.
Longitudinal studies are needed to assess this potential
clinical application of DTI.
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